This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Keloid Treatment Market

Keloid Treatments: Unique and Minimally Invasive Treatment Approaches That Don’t Let Keloids Scar Your Skin and Confidence! Find Out More with FMI

Keloid Treatment Market by Treatment, End User & Region - Forecast 2022 – 2032

Keloid Treatment Market Outlook (2022-2032)

[250 Pages Report] The global keloid treatment market size reached US$ 3.6 Bn in 2021 and is expected to enjoy a valuation of US$ 3.7 Bn by the end of 2022. Furthermore, with rising prevalence of keloid across the world, the overall demand for keloid treatment is set to grow at 3.2% CAGR between 2022 and 2032, totalling a valuation of ~US$ 5.1 Bn by 2032.

Among various types of treatments, the intralesional corticosteroid injections segment dominated the global keloid treatment market with a share of about 28.3% in 2021 and the trend is likely to continue during the forecast period.

Attribute

Key Statistics

Keloid Market Base Value (2021)

US$ 3.6 Bn

Estimated Market Value (2022)

US$ 3.7 Bn

Projected Market Value (2032)

US$ 5.1 Bn

Value-based CAGR (2022-2032)

3.2%

Market Share of Top 5 Countries

60.7%

Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection.

Scars can be treated in a variety of ways with varying degrees of success. Nonsurgical treatments, which aim to slow the appearance of scars, enhance their looks, and restore function, have grown to be of utmost importance.

Factors such as increase in the number of road accidents and burn cases, advancements in keloid treatment approaches, and rising popularity of aesthetic surgeries are playing crucial roles in accelerating the growth of keloid treatment market.

The keloid treatment market formed approximately 29.5% of the overall ~US$ 14.1 Bn global scar treatment market in 2021 and this number is likely to further increase during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Keloid Treatment from 2012 to 2021 Vs Market Outlook for 2022 to 2032

The global sales of keloid treatment are projected to grow at 3.2% CAGR between 2022 and 2032, in comparison to 3.5% CAGR registered during the historical period of 2012 to 2021. Increasing incidence of wound and injury-related cases, rising number of aesthetic surgeries being performed worldwide, and growing adoption of various keloid treatments are some of the key factors expected to drive growth in the global market.

Similarly, rising preference for minimally invasive procedures will further accelerate the growth of keloid treatment market during the next ten years.

Clinicians have assessed the potential of anti-inflammatory and chemotherapeutic molecules to inhibit keloid recurrence in addition to conducting studies to enhance the use of conventional therapies, such as steroids and radiation. Cryotherapy and lasers, two procedure-focused therapies, have also been demonstrated to be effective in lowering keloid symptomatology.

Keloids are distinguished as being more clinically severe in nature than hypertrophic scars, commonly causing itching and pain in patients. In contrast to hypertrophic scars, which can heal naturally over years, keloids grow to produce thick, stiff scars that seldom heal on their own. The fundamental elements of keloid pathogenesis have attracted a lot of attention since keloids can be distressing for patients.

The variety of therapy available for the prevention and treatment of keloids is constantly growing, and optimistic technological breakthroughs from innovative methodologies have contributed to this growth. Reliable information about the consistent use of the various injectable therapies and devices reported in the literature can be collected as doctors get more experience using them.

There are currently no accepted standards for keloid management that have the approval of an academic governing body. As a result, there are many prospects for research and development of treatment modalities to provide a variety of treatments for keloids as a standardized measure of care in the market for keloid treatment.

Thus, increasing investments in R&D in this sphere is expected to create lucrative growth opportunities for leading providers during the forecast period.

Keloid Treatment Market Download Report Brochure

What are the Key Trends Driving the Keloid Treatment Market?

“Advancements in Keloid Treatments to Present an Array of Opportunities for Market Growth”

In addition to the already available conventional treatment options, improvements in the knowledge of the molecular mechanisms underlying keloids and hypertrophic scars have ushered in a new age of drug discovery and the development of novel, emerging anti-pathologic scar treatments.

Interferons, which have shown great success in treating high-risk melanomas, are one of a few emerging treatments that are widely used in a variety of skin conditions like condyloma acuminate and basal cell carcinoma.

Verapamil, an antihypertensive medication, works on keloids and hypertrophic scars by lowering calcium levels inside the cells. For patients with keloids, autologous fat grafting (also known as lipotransfer) of adipose tissue-derived stem cells (ADSCs) has been proven to enhance scar texture, pliability volume, and elasticity.

Mesenchymal stem cells (MSCs) have shown a strong ability to enhance healing of wounds and regeneration by secreting differentiation and growth factors that promote migration, angiogenesis, and up-regulate epithelialization and collagen remodeling.

Over the projected years, market participants will have access to a wide range of profitable growth prospects due to the availability of treatments for keloids.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Growth of Keloid Treatment Market?

Many therapeutic approaches have been explored for the prevention and reduction of keloids and hypertrophic scars, but none of them are beneficial in all patients. There is currently no recognized global standard of care for treatment, and the evidence-based literature is limited.

Keloid and hypertrophic scars are a constant issue for patients and clinicians, despite the many targeted options that are currently available. No one therapy has, as of now, been regarded as the gold standard for all excessive scarring, nor has it been able to eliminate scarring. These factors will therefore continue to have a negative impact on the overall market growth.

Country-wise Insights

Will the U.S. Continue to Retain its Dominant Position in North American Keloid Treatment Market?

“Rise in Cases of Burn Injuries and Road Accidents to Bolster Market Growth in the U.S.”

The U.S. dominated North American keloid treatment market in 2021 with a total market share of about 88.0% and is expected to continue to experience the same growth throughout the forecast period.

Growth in the U.S. keloid treatment market is driven by rising prevalence of accidents, injuries, as well as dermal illnesses, presence of highly sophisticated healthcare facilities, and high levels of healthcare awareness among people.

According to a report published in 2016 by the American Burn Association, there were around 486,000 burn injury cases reported in the U.S that received medical treatment. This rise in burn accidents is expected to foster the growth of keloid treatment in the country during the assessment period.

What is the Demand Outlook for Keloid Treatment Market in Germany?

“Booming Medical Tourism Pushing Demand for Keloid Treatments in Germany”

As per FMI, the keloid treatment market in Germany is set to exhibit a CAGR of nearly 4.5% during the forecast period owing to the flourishing medical tourism, presence of advanced equipment for dermatology and cosmetic procedures, and increasing spending by people on cosmetic procedures.

Similarly, rapid expansion of healthcare industry and increasing prevalence of keloid disorder among the German population will bode well for the keloid market during the assessment period.

How is Keloid Treatment Market Shaping Up in China?

“Increasing Investments in R&D to Supplement Market Growth in China”

China held a market share of around 9.1% in the global keloid treatment market in 2021 and it is anticipated to witness a steady growth rate during the forecast period. There are vast developments in research-based activities within the country, and this factor is expected to provide traction to the overall market growth.

Moreover, with a high population density and favourable government support, the country is expected to provide a large share of revenue within the global keloid treatment market, throughout the forecast years.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which is the Most Popular Treatment for Keloid?

“Intralesional Corticosteroid Injections Will Remain the Most Preferred Treatment for Keloid”

As per FMI, the intralesional corticosteroid injections segment is expected to grow at the highest CAGR of 2.5% between 2022 and 2032, accounting for a market share of about 26.3% in the global keloid treatment market in 2032. This can be attributed to the rising preference of patients for opting for intralesional corticosteroid injections due to their higher effectiveness.

The most often used treatment option for keloid scars is the intralesional injection, preferably separately or in combination with 5-FU, verapamil, and bleomycin. In the nonsurgical treatment of hypertrophic and keloid scars, it is considered to be the gold standard.

Which End User Contributes Most to the Global Keloid Treatment Market?

“Demand for Keloid Treatment to Remain High in Hospitals”

Hospitals segment held the highest market share value of around 37.0% in 2021 and is poised to grow at a higher growth rate during the assessment period. This can be attributed to the rising number of hospitals across the world and easy availability of various keloid treatments at lower prices in government hospitals.

Similarly, rising inclination of patients to opt for keloid treatments in hospitals due to presence of well-trained medical professionals will bode well for the market growth during the forecast period.

Competitive Landscape

The keloid treatment market is highly fragmented due to the presence of numerous rivals in this space. Leading businesses are employing strategies including mergers and acquisitions, alliances and collaborations, and new product releases to satisfy consumer demand and increase their client base.

Some of the recent developments in keloid treatment market are listed below:

  • Two Singapore approvals of Sonoma Pharmaceuticals' Microcyn® (hypochlorous acid) for the treatment of atopic dermatitis and hypertrophic / keloid scars were announced in June 2017.
  • The RECELL® System for the treatment of acute burns was covered by insurance in Japan, according to an announcement made by AVITA Medical, Inc. in September 2022 by COSMOTEC, an M3 Group Company.
  • In February 2022, Avita Medical Inc., received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) in Japan to market the RECELL System in Japan.
  • In April 2021, Sensus Healthcare announced the installation of its 500Th SRT unit.

Report Scope-Keloid Treatment Market

Attribute

Details

Estimated Market Size (2022)

US$ 3.7 Bn

Projected Market Size (2032)

US$ 5.1 Bn

Anticipated Growth Rate (2022-2032)

3.2%

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa

Key Market Segments Covered

Treatment, End User, and Region

Key Companies Profiled

  • Novartis AG
  • Sensus Healthcare
  • RXi Pharmaceuticals, Inc.
  • Sonoma Pharmaceuticals, Inc.
  • Perrigo Company plc.
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Revitol Corporation
  • Avita Medical Limited

Report Coverage

Market forecast, brand share analysis, competition intelligence, DROT analysis, market dynamics and challenges, strategic growth initiatives

Key Market Segments Covered in Keloid Treatment Industry Research

By Treatment:

  • Occlusive Dressing
  • Compression Therapy
  • Cryosurgery
  • Excision
  • Radiation Therapy
  • Laser Therapy
  • Interferon Therapy
  • Intralesional Corticosteroid Injections
  • Others

By End User:

  • Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global keloid treatment market was valued at US$ 3.6 Bn in 2021 and is expected to reach US$ 3.7 Bn in 2022.

As per FMI, the global keloid treatment market is expected to register a CAGR of 3.2% between 2022 and 2032.

The global keloid treatment market is anticipated to reach a valuation of US$ 5.1 Bn by 2032.

Growing incidence of accidents and injury cases, surge in genetic and dermatological diseases, and the rising adoption of non-invasive procedures are some of the key trends shaping growth of the keloid treatment market.

The U.S., China, Japan, Brazil, and Germany are top 5 countries driving demand for the keloid treatments.

The U.S. accounted for about 88.0% of the North American keloid treatment market in 2021.

Demand for keloid treatment in Germany is expected to grow at 4.5% over the next ten years.

The U.S., China, and Japan are the key producers of keloid treatments.

Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, are some of the key players in the keloid treatment industry.

The keloid treatment market in China is set to expand at a CAGR of 3.6% over the forecast period.

The Japan keloid treatment market is set to expand at a CAGR of 2.9% over the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Treatment Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Prevalence

    4.2. Promotional Strategies, By Key Manufacturers

    4.3. Key Regulations

    4.4. Value Chain Analysis

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Scar Treatment Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Incidence of Wound/Injury

        5.2.2. Growing Adoption of Aesthetic Surgical Procedures

        5.2.3. Rise in Medical Tourism

        5.2.4. Introduction of Laser Therapy Devices

        5.2.5. Development of Novel Therapeutic Formulations

        5.2.6. Adoption of Radiation Therapy for Keloid Treatment

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Treatment

        6.1.2. By End User

        6.1.3. By Country

    6.2. 2021 Market Scenario

7. Global Keloid Treatment Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Treatment

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Keloid Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032

    8.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By Treatment

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2012 - 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2022 - 2032

        9.3.1. Occlusive Dressing

        9.3.2. Compression Therapy

        9.3.3. Cryosurgery

        9.3.4. Excision

        9.3.5. Radiation Therapy

        9.3.6. Laser Therapy

        9.3.7. Interferon Therapy

        9.3.8. Intralesional Corticosteroid Injections

        9.3.9. Others

    9.4. Market Attractiveness Analysis By Treatment

10. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2012 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2032

        10.3.1. Hospitals

        10.3.2. Dermatology Clinics

        10.3.3. ASCs

        10.3.4. Others

    10.4. Market Attractiveness Analysis By End User

11. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Treatment

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Treatment

        12.4.3. By End User

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. U.S. Keloid Treatment Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast By Market Taxonomy

                12.8.1.2.1. By Country

                12.8.1.2.2. By Treatment

                12.8.1.2.3. By End User

        12.8.2. Canada Keloid Treatment Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast By Market Taxonomy

                12.8.2.2.1. By Country

                12.8.2.2.2. By Treatment

                12.8.2.2.3. By End User

13. Latin America Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

                13.3.1.4.1. By Country

                13.3.1.4.2. By Treatment

                13.3.1.4.3. By End User

    13.4. Market Attractiveness Analysis

                13.4.1.1.1. By Country

                13.4.1.1.2. By Treatment

                13.4.1.1.3. By End User

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Keloid Treatment Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast By Market Taxonomy

                13.8.1.2.1. By Treatment

                13.8.1.2.2. By End User

        13.8.2. Brazil Keloid Treatment Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast By Market Taxonomy

                13.8.2.2.1. By Country

                13.8.2.2.2. By Treatment

                13.8.2.2.3. By End User

        13.8.3. Argentina Keloid Treatment Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast By Market Taxonomy

                13.8.3.2.1. By Treatment

                13.8.3.2.2. By End User

14. Europe Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Nordic Countries

            14.3.1.9. Rest of Europe

        14.3.2. By Treatment

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Treatment

        14.4.3. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Germany Keloid Treatment Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Treatment

                14.8.1.2.2. By End User

        14.8.2. Italy Keloid Treatment Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Treatment

                14.8.2.2.2. By End User

        14.8.3. France Keloid Treatment Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast By Market Taxonomy

                14.8.3.2.1. By Treatment

                14.8.3.2.2. By End User

        14.8.4. U.K. Keloid Treatment Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast By Market Taxonomy

                14.8.4.2.1. By Treatment

                14.8.4.2.2. By End User

        14.8.5. Spain Keloid Treatment Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast By Market Taxonomy

                14.8.5.2.1. By Treatment

                14.8.5.2.2. By End User

        14.8.6. BENELUX Keloid Treatment Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast By Market Taxonomy

                14.8.6.2.1. By Treatment

                14.8.6.2.2. By End User

        14.8.7. Russia Keloid Treatment Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast By Market Taxonomy

                14.8.7.2.1. By Treatment

                14.8.7.2.2. By End User

        14.8.8. Nordic Countries Keloid Treatment Market Analysis

            14.8.8.1. Introduction

            14.8.8.2. Market Analysis and Forecast By Market Taxonomy

                14.8.8.2.1. By Treatment

                14.8.8.2.2. By End User

15. East Asia Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Treatment

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Treatment

        15.4.3. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. China Keloid Treatment Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Treatment

                15.8.1.2.2. By End User

        15.8.2. Japan Keloid Treatment Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Treatment

                15.8.2.2.2. By End User

        15.8.3. South Korea Keloid Treatment Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Treatment

                15.8.3.2.2. By End User

16. South Asia Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Indonesia

            16.3.1.3. Malaysia

            16.3.1.4. Thailand

            16.3.1.5. Rest of South Asia

        16.3.2. By Treatment

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Treatment

        16.4.3. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. India Keloid Treatment Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Treatment

                16.8.1.2.2. By End User

        16.8.2. Indonesia Keloid Treatment Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Treatment

                16.8.2.2.2. By End User

        16.8.3. Malaysia Keloid Treatment Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Treatment

                16.8.3.2.2. By End User

        16.8.4. Thailand Keloid Treatment Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast By Market Taxonomy

                16.8.4.2.1. By Treatment

                16.8.4.2.2. By End User

17. Oceania Keloid Treatment Market 2012-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Treatment

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Treatment

        17.4.3. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. Australia Keloid Treatment Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast By Market Taxonomy

                17.7.1.2.1. By Treatment

                17.7.1.2.2. By End User

        17.7.2. New Zealand Keloid Treatment Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast By Market Taxonomy

                17.7.2.2.1. By Treatment

                17.7.2.2.2. By End User

18. Middle East and Africa (MEA) Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. North Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Treatment

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Treatment

        18.4.3. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Keloid Treatment Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast By Market Taxonomy

                18.8.1.2.1. By Treatment

                18.8.1.2.2. By End User

        18.8.2. Turkey Keloid Treatment Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast By Market Taxonomy

                18.8.2.2.1. By Treatment

                18.8.2.2.2. By End User

        18.8.3. South Africa Keloid Treatment Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast By Market Taxonomy

                18.8.3.2.1. By Treatment

                18.8.3.2.2. By End User

        18.8.4. North Africa Keloid Treatment Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast By Market Taxonomy

                18.8.4.2.1. By Treatment

                18.8.4.2.2. By End User

19. Market Structure Analysis

    19.1. Market Analysis By Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis (%) of Top Players

    19.4. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Novartis AG

            20.3.1.1. Overview

            20.3.1.2. Treatment Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Key Financials

            20.3.1.5. SWOT Analysis

            20.3.1.6. Strategic Overview

        20.3.2. Sensus Healthcare

            20.3.2.1. Overview

            20.3.2.2. Treatment Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Key Financials

            20.3.2.5. SWOT Analysis

            20.3.2.6. Strategic Overview

        20.3.3. RXi Pharmaceuticals, Inc.

            20.3.3.1. Overview

            20.3.3.2. Treatment Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Key Financials

            20.3.3.5. SWOT Analysis

            20.3.3.6. Strategic Overview

        20.3.4. Sonoma Pharmaceuticals, Inc.

            20.3.4.1. Overview

            20.3.4.2. Treatment Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Key Financials

            20.3.4.5. SWOT Analysis

            20.3.4.6. Strategic Overview

        20.3.5. Perrigo Company plc.

            20.3.5.1. Overview

            20.3.5.2. Treatment Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Key Financials

            20.3.5.5. SWOT Analysis

            20.3.5.6. Strategic Overview

        20.3.6. Bristol-Myers Squibb Company

            20.3.6.1. Overview

            20.3.6.2. Treatment Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Key Financials

            20.3.6.5. SWOT Analysis

            20.3.6.6. Strategic Overview

        20.3.7. Pacific World Corporation

            20.3.7.1. Overview

            20.3.7.2. Treatment Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Key Financials

            20.3.7.5. SWOT Analysis

            20.3.7.6. Strategic Overview

        20.3.8. Valeant Pharmaceuticals International, Inc.

            20.3.8.1. Overview

            20.3.8.2. Treatment Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Key Financials

            20.3.8.5. SWOT Analysis

            20.3.8.6. Strategic Overview

        20.3.9. Revitol Corporation

            20.3.9.1. Overview

            20.3.9.2. Treatment Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Key Financials

            20.3.9.5. SWOT Analysis

            20.3.9.6. Strategic Overview

        20.3.10. Avita Medical Limited

            20.3.10.1. Overview

            20.3.10.2. Treatment Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Key Financials

            20.3.10.5. SWOT Analysis

            20.3.10.6. Strategic Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 02: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 03: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 04: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 05: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Region 2012-2021

Table 06: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Region, 2022-2032

Table 07: North America Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021

Table 08: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 09: North America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 10: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 11: North America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 12: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 13: Latin America Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021

Table 14: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 15: Latin America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 16: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 17: Latin America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 18: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 19: Europe Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021

Table 20: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 21: Europe Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 22: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 23: Europe Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 24: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 25: South Asia Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021

Table 26: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 27: South Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 28: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 29: South Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 30: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 31: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 32: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 33: East Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 34: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 35: East Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 36: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 37: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 38: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 39: Oceania Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 40: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 41: Oceania Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 42: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Table 43: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 44: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032

Table 45: MEA Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021

Table 46: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032

Table 47: MEA Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021

Table 48: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 02: Global Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 03: Global Keloid Treatment Market Absolute $ Opportunity, 2022-2032

Figure 04: Global Keloid Treatment Market Share Analysis (%) By Treatment, 2022 & 2032

Figure 05: Global Keloid Treatment Market Y-o-Y Growth (%) By Treatment, 2022-2032

Figure 06: Global Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 07: Global Keloid Treatment Market Share Analysis (%) By End User, 2022 & 2032

Figure 08: Global Keloid Treatment Market Y-o-Y Growth (%) By End User, 2022-2032

Figure 09: Global Keloid Treatment Market Attractiveness Analysis, By End User

Figure 10: Global Keloid Treatment Market Share Analysis (%) By Region, 2022 & 2032

Figure 11: Global Keloid Treatment Market Y-o-Y Growth (%) By Region, 2022-2032

Figure 12: Global Keloid Treatment Market Attractiveness Analysis, By Region

Figure 13: North America Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 14: North America Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 15: North America Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 16: North America Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 17: North America Keloid Treatment Market Attractiveness Analysis, By Country

Figure 18: North America Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 19: North America Keloid Treatment Market Attractiveness Analysis, By End User

Figure 20: U.S. Market Value Proportion Analysis, 2022

Figure 21: Global Vs U.S. Y-o-Y Growth Comparison, 2021-2032

Figure 22: U.S. Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 23: U.S. Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 24: Canada Market Value Proportion Analysis, 2022

Figure 25: Global Vs Canada Y-o-Y Growth Comparison, 2021-2032

Figure 26: Canada Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 27: Canada Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 28: Latin America Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 29: Latin America Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 30: Latin America Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 31: Latin America Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 32: Latin America Keloid Treatment Market Attractiveness Analysis, By Country

Figure 33: Latin America Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 34: Latin America Keloid Treatment Market Attractiveness Analysis, By End User

Figure 35: Brazil Market Value Proportion Analysis, 2022

Figure 36: Global Vs Brazil Y-o-Y Growth Comparison, 2021-2032

Figure 37: Brazil Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 38: Brazil Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 39: Mexico Market Value Proportion Analysis, 2022

Figure 40: Global Vs Mexico Y-o-Y Growth Comparison, 2021-2032

Figure 41: Mexico Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 42: Mexico Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 43: Argentina Market Value Proportion Analysis, 2022

Figure 44: Global Vs Argentina Y-o-Y Growth Comparison, 2021-2032

Figure 45: Argentina Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 46: Argentina Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 47: Europe Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 48: Europe Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 49: Europe Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 50: Europe Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 51: Europe Keloid Treatment Market Attractiveness Analysis, By Country

Figure 52: Europe Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 53: Europe Keloid Treatment Market Attractiveness Analysis, By End User

Figure 54: U.K. Market Value Proportion Analysis, 2022

Figure 55: Global Vs U.K. Y-o-Y Growth Comparison, 2021-2032

Figure 56: U.K. Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 57: U.K. Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 58: Germany Market Value Proportion Analysis, 2022

Figure 59: Global Vs Germany Y-o-Y Growth Comparison, 2021-2032

Figure 60: Germany Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 61: Germany Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 62: Italy Market Value Proportion Analysis, 2022

Figure 63: Global Vs Italy Y-o-Y Growth Comparison, 2021-2032

Figure 64: Italy Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 65: Italy Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 66: France Market Value Proportion Analysis, 2022

Figure 67: Global Vs France Y-o-Y Growth Comparison, 2021-2032

Figure 68: France Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 69: France Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 70: Spain Market Value Proportion Analysis, 2022

Figure 71: Global Vs Spain Y-o-Y Growth Comparison, 2021-2032

Figure 72: Spain Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 73: Spain Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 74: Russia Market Value Proportion Analysis, 2022

Figure 75: Global Vs Russia Y-o-Y Growth Comparison, 2021-2032

Figure 76: Russia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 77: Russia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 78: Nordic Countries Market Value Proportion Analysis, 2022

Figure 79: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2021-2032

Figure 80: Nordic Countries Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 81: Nordic Countries Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 82: BENELUX Market Value Proportion Analysis, 2022

Figure 83: Global Vs BENELUX Y-o-Y Growth Comparison, 2021-2032

Figure 84: BENELUX Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 85: BENELUX Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 86: South Asia Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 87: South Asia Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 88: South Asia Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 89: South Asia Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 90: South Asia Keloid Treatment Market Attractiveness Analysis, By Country

Figure 91: South Asia Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 92: South Asia Keloid Treatment Market Attractiveness Analysis, By End User

Figure 93: India Market Value Proportion Analysis, 2022

Figure 94: Global Vs India Y-o-Y Growth Comparison, 2021-2032

Figure 95: India Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 96: India Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 97: Thailand Market Value Proportion Analysis, 2022

Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2021-2032

Figure 99: Thailand Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 100: Thailand Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 101: Indonesia Market Value Proportion Analysis, 2022

Figure 102: Global Vs Indonesia Y-o-Y Growth Comparison, 2021-2032

Figure 103: Indonesia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 104: Indonesia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 105: Malaysia Market Value Proportion Analysis, 2022

Figure 106: Global Vs Malaysia Y-o-Y Growth Comparison, 2021-2032

Figure 107: Malaysia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 108: Malaysia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 109: East Asia Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 110: East Asia Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 111: East Asia Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 112: East Asia Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 113: East Asia Keloid Treatment Market Attractiveness Analysis, By Country

Figure 114: East Asia Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 115: East Asia Keloid Treatment Market Attractiveness Analysis, By End User

Figure 116: China Market Value Proportion Analysis, 2022

Figure 117: Global Vs China Y-o-Y Growth Comparison, 2021-2032

Figure 118: China Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 119: China Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 120: Japan Market Value Proportion Analysis, 2022

Figure 121: Global Vs Japan Y-o-Y Growth Comparison, 2021-2032

Figure 122: Japan Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 123: Japan Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 124: South Korea Market Value Proportion Analysis, 2022

Figure 125: Global Vs South Korea Y-o-Y Growth Comparison, 2021-2032

Figure 126: South Korea Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 127: South Korea Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 128: Oceania Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 129: Oceania Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 130: Oceania Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 131: Oceania Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 132: Oceania Keloid Treatment Market Attractiveness Analysis, By Country

Figure 133: Oceania Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 134: Oceania Keloid Treatment Market Attractiveness Analysis, By End User

Figure 135: Australia Market Value Proportion Analysis, 2022

Figure 136: Global Vs Australia Y-o-Y Growth Comparison, 2021-2032

Figure 137: Australia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 138: Australia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 139: New Zealand Market Value Proportion Analysis, 2022

Figure 140: Global Vs New Zealand Y-o-Y Growth Comparison, 2021-2032

Figure 141: New Zealand Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 142: New Zealand Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 143: Middle East and Africa (MEA) Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country

Figure 144: Middle East and Africa (MEA) Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022

Figure 145: MEA Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021

Figure 146: MEA Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032

Figure 147: MEA Keloid Treatment Market Attractiveness Analysis, By Country

Figure 148: MEA Keloid Treatment Market Attractiveness Analysis, By Treatment

Figure 149: MEA Keloid Treatment Market Attractiveness Analysis, By End User

Figure 150: GCC Countries Market Value Proportion Analysis, 2022

Figure 151: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021-2032

Figure 152: GCC Countries Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 153: GCC Countries Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 154: Turkey Market Value Proportion Analysis, 2022

Figure 155: Global Vs Turkey Y-o-Y Growth Comparison, 2021-2032

Figure 156: Turkey Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 157: Turkey Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 158: North Africa Market Value Proportion Analysis, 2022

Figure 159: Global Vs North Africa Y-o-Y Growth Comparison, 2021-2032

Figure 160: North Africa Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 161: North Africa Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Figure 162: South Africa Market Value Proportion Analysis, 2022

Figure 163: Global Vs South Africa Y-o-Y Growth Comparison, 2021-2032

Figure 164: South Africa Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032

Figure 165: South Africa Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Dermatology Cryosurgery Units Market

Published : September 2017

Healthcare

Dermatology Devices Market

Published : November 2016

Healthcare

Wound Debridement Products Market

Published : March 2021

Google translate

Keloid Treatment Market